-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

Benzinga·09/25/2026 09:38:20
Listen to the news
Keybanc analyst Matthew Gillmor initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $18.